Table 2 Indications for surgery, heart valve intervention (type and position) and follow-up data
From: Mid-term follow-up and outcomes of patients with prosthetic heart valves: a single-centre experience
N (%) | |
|---|---|
Indication for surgery | |
Aortic stenosis | 199 (67.7) |
Mitral regurgitation | 33 (11.2) |
Infective endocarditis | 19 (6.5) |
Other | 43 (14.6) |
Prosthesis/repair type and position | |
Bioprosthetic—AVR | 192 (65.3) |
Mechanical—AVR | 46 (15.6) |
Bioprosthetic—MVR | 13 (4.4) |
Mechanical—MVR | 3 (1.0) |
AVR and MVR (bioprosthetic) | 4 (1.3) |
TAVI | 14 (4.7) |
MV repair ± annuloplasty ring | 26 (8.8) |
TVR (with bioprosthetic AVR) | 6 (3.1) |
TVR (with mechanical MVR) | 1(33.3) |
TVR (with mitral valve repair ± annuloplasty ring) | 3(11.5) |
Follow-up | |
Baseline TTE | 109 (37.1) |
Annual TTE and clinical review | 243 (82.6) |